From enhancing lesions to brain atrophy in relapsing MS

J H Simon1

  • 1Department of Radiology, University of Colorado Health Sciences Center, Denver 80262, USA. jsimon@ewok.uhcolorado.edu

Insights

Multiple Sclerosis (MS) lesions evolve from inflammatory to chronic stages. Early inflammatory MS lesions predict later brain atrophy, suggesting a link to axonal injury.

Area of Science:

  • Neuroimaging
  • Neurology
  • Pathophysiology

Background:

  • Multiple Sclerosis (MS) lesions undergo a natural progression observed via Magnetic Resonance (MR) imaging.
  • Lesions evolve from acute, enhancing inflammatory stages to chronic, T2 hyperintense lesions, serving as non-specific markers of past events.

Purpose of the Study:

  • To investigate the relationship between early MS lesion characteristics and the development of cerebral atrophy.
  • To explore whether prior enhancing lesions predict subsequent volume loss in the brain.

Main Methods:

  • Longitudinal evaluation of patients with MS using MR imaging.
  • Analysis of lesion evolution from acute enhancing to chronic T2 hyperintense stages.
  • Assessment of cerebral atrophy, specifically volume loss around the third ventricle.

Main Results:

  • Accumulation of non-specific chronic T2 lesions occurs alongside significant cerebral atrophy, even in patients with mild disability.
  • The presence of prior, temporally and anatomically distant enhancing lesions predicts cerebral atrophy.
  • Volume loss around the third ventricle is particularly associated with prior enhancing lesions.

Conclusions:

  • Early inflammatory events in MS, represented by enhancing lesions, initiate processes leading to cerebral atrophy.
  • Axonal injury may be an early mechanism contributing to the development of cerebral atrophy in MS.
  • Understanding this progression may offer insights into early therapeutic interventions for MS.

Related Concept Videos

Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...